Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1 Национальный медицинский исследовательский центр психиатрии и неврологии им. В.М. Бехтерева (ФГБУ «НМИЦ ПН им. В.М. Бехтерева» Минздрава России) 2 Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова (ФГБОУ ВО «ПСПбГМУ им. И.П. Павлова» Минздрава России)
Список исп. литературыСкрыть список 1. Касьянов Е.Д., Кибитов А.О., Мазо Г.Э. Расстройства настроения в семейном анамнезе как фактор риска рекуррентного депрессивного или биполярного аффективного расстройства: результаты кросс-секционного исследования. Психиатрия. – 2023. – Т. 21, № 4. – С. 49-56. – DOI 10.30629/ 2618-6667-2023-21-4-49-56 2. Касьянов Е.Д. Клинические и генетические маркеры риска развития аффективных нарушений в семьях с отягощенным анамнезом по депрессивному и биполярному аффективному расстройствам: специальность 14.01.06 «Психиатрия»: диссертация на соискание ученой степени кандидата медицинских наук / Касьянов Евгений Дмитриевич, 2021. – 122 с. 3. Мазо Г.Э., Незнанов Н.Г., Рукавишников Г.В. Психосоматическая медицина: старые ресурсы и новые технологии. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2023;123(4‑2):14‑19. 4. Рукавишников Г.В., Ракитько А.С., Касьянов Е.Д., Ильинский В.В., Малышко Л.В., Незнанов Н.Г., Кибитов А.О., Мазо Г.Э. Связь депрессии и тревоги с соматическими заболеваниями: роль негативных внешних факторов. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2023;123(4‑2):74‑80. 5. Angst J, Adolfsson R, Benazzi F, et al. The HCL-32: towards a self-assessment tool for hypomanic symptoms in outpatients. J Affect Disord. 2005;88(2):217-233. doi:10.1016/j.jad.2005.05.011 6. Belleau EL, Treadway MT, Pizzagalli DA. The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology. Biol Psychiatry. 2019 Mar 15;85(6):443-453. doi: 10.1016/j.biopsych. 2018.09.031 7. Berk M, Köhler-Forsberg O, Turner M, Penninx BWJH, Wrobel A, Firth J, Loughman A, Reavley NJ, McGrath JJ, Momen NC, Plana-Ripoll O, O'Neil A, Siskind D, Williams LJ, Carvalho AF, Schmaal L, Walker AJ, Dean O, Walder K, Berk L, Dodd S, Yung AR, Marx W. Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management. World Psychiatry. 2023 Oct;22(3):366-387. doi: 10.1002/wps.21110 8. Bernstein D.P., Fink L. Childhood Trauma Questionnaire, A Retrospective Self-report: Manual. NCS Pearson; San Antonio, TX, USA: 1998. 9. Brailean A, Curtis J, Davis K, Dregan A, Hotopf M. Characteristics, comorbidities, and correlates of atypical depression: evidence from the UK Biobank Mental Health Survey. Psychol Med. 2020;50(7):1129-1138. doi:10.1017/ S0033291719001004 10. Bush DE, Ziegelstein RC, Patel UV, Thombs BD, Ford DE, Fauerbach JA, McCann UD, Stewart KJ, Tsilidis KK, Patel AL, Feuerstein CJ, Bass EB. Post-myocardial infarction depression. Evid Rep Technol Assess (Summ). 2005 May;(123):1-8. 11. Clarke DM, Currie KC. Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence. Med J Aust. 2009;190(S7):S54-S60. doi:10.5694/j.1326-5377.2009.tb02471.x 12. Chang, C.K., Hayes, R.D., Broadbent, M., Fernandes, A.C., Lee, W., Hotopf, M., Stewart, R., 2010. All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: A cohort study. BMC Psychiatry. 2010 Sep 30;10:77. doi: 10.1186/1471-244X-10-77 13. Coello K., Kjærstad H. L., Stanislaus S. Thirty-year cardiovascular risk score in patients with newly diagnosed bipolar disorder and their unaffected first-degree relatives // Australian & New Zealand Journal of Psychiatry. 2018. .doi:10.1177/0004867418815987. 14. Evans DL, Charney DS, Lewis L, et al. Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry 2005; 58: 175-189. AND Knol MJ, Twisk JWR, Beekman ATF, et al. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006; 49: 837-845. 15. Gold DT, Solimeo S. Osteoporosis and depression: a historical perspective. Curr Osteoporos Rep 2006; 4: 134-139 16. Gürhan N, Beşer NG, Polat Ü, Koç M. Suicide Risk and Depression in Individuals with Chronic Illness. Community Ment Health J. 2019;55(5):840-848. doi:10.1007/s10597-019-00388-7 17. Hegeman JM, van Fenema EM, Comijs HC, Kok RM, van der Mast RC, de Waal MWM. Effect of chronic somatic diseases on the course of late-life depression. Int J Geriatr Psychiatry. 2017 Jul;32(7):779-787. doi: 10.1002/gps.4523. Epub 2016 Jun 7. PMID: 27273023 18. Katon WJ. Epidemiology and treatment of depression in patients with chronic medical illness. Dialogues Clin Neurosci. 2011;13(1):7-23. doi:10.31887/DCNS.2011.13.1/wkaton 19. Kennedy GJ, Kelman HR, Thomas C. Persistence and remission of depressive symptoms in late life. Am J Psychiatry. 1991;148(2):174-178. doi:10.1176/ajp.148.2.174 20. Khandaker GM, Zuber V, Rees JMB, Carvalho L, Mason AM, Foley CN, Gkatzionis A, Jones PB, Burgess S. Shared mechanisms between coronary heart disease and depression: findings from a large UK general population-based cohort. Mol Psychiatry. 2020 Jul;25(7):1477-1486. doi: 10.1038/s41380-019-0395-3. 21. Kim YH, Jung KI, Song CH. Men With Both Diabetes and a Family History of Diabetes Were Associated With Depressed Mood in Korean Adults. Am J Mens Health. 2023 May-Jun;17(3):15579883231180982. doi: 10.1177/ 15579883231180982 22. Lamers F, Milaneschi Y, de Jonge P, Giltay EJ, Penninx BWJH. Metabolic and inflammatory markers: associations with individual depressive symptoms. Psychol Med. 2018;48(7):1102-1110. doi:10.1017/ S0033291717002483 23. Luber, M., Williams-Russo, P., DiDomenico, T.N., Meyers, B.S., Alexopoulos, G.S., Charlson, M.E., 2000. Diagnosis, treatment, comorbidity and resource utilization of depressed patients in a general medical practice. Int. J. Psychiatry Med. 30, 1-13 24. Ma Y, Xiang Q, Yan C, Liao H, Wang J. Relationship between chronic diseases and depression: the mediating effect of pain. BMC Psychiatry. 2021;21(1):436. Published 2021 Sep 6. doi:10.1186/s12888-021- 03428-3 25. Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., Ustun, B., 2007. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 370, 851-858. 26. Posner K, Brown GK, Stanley B, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168(12):1266-1277. doi:10.1176/appi.ajp.2011.10111704 27. Read JR, Sharpe L, Modini M, Dear BF. Multimorbidity and depression: a systematic review and meta-analysis. J Affect Disord. 2017;221:36–46. https://doi.org/10.1016/j.jad.2017.06.009. 28. Rukavishnikov GV, Rakitko AS, Kasyanov ED, Ilinsky VV, Malyshko LV, Neznanov NG, Kibitov AO, Mazo GE. Association of depression and anxiety with somatic diseases: negative lifestyle factors impact. Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(4. Vyp. 2):74-80. Russian. doi: 10.17116/jnevro202312304274. 29. Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry. 1995;167(1):99-103. doi:10.1192/bjp.167.1.99 30. Toma S., Fiksenbaum L., Omrin D., Goldstein B.I. Elevated Familial Cardiovascular Burden Among Adolescents With Familial Bipolar Disorder // Front. Psychiatry. 2019. V. 10. P. 8. doi: 10.3389/fpsyt.2019.00008 31. Topic R, Milicic D, Stimac Z, et al. Somatic comorbidity, metabolic syndrome, cardiovascular risk, and CRP in patients with recurrent depressive disorders. Croat Med J. 2013;54(5):453-459. doi:10.3325/cmj.2013.54.453 32. van Dixhoorn J, White A. Relaxation therapy for rehabilitation and prevention in ischaemic heart disease: a systematic review and metaanalysis. Eur J Cardiovasc Prev Rehabil 2005; 12: 193-202. 33. Walker AJ, Kim Y, Price JB, Kale RP, McGillivray JA, Berk M, Tye SJ. Stress, Inflammation, and Cellular Vulnerability during Early Stages of Affective Disorders: Biomarker Strategies and Opportunities for Prevention and Intervention. Front Psychiatry. 2014 Apr 9;5:34. doi: 10.3389/fpsyt.2014.00034